Top Markets
Coin of the day
Clarity Pharmaceuticals Ltd Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd

CU6
Rangering i aksjer #11775
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company,... Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Aksjekurs
$1.77
Sist synkronisert: 2026-08-28
Markedsverdi
$660.45M
Endring (1 dag)
7.26%
Endring (1 år)
-9.15%
Land
AU
Handel Clarity Pharmaceuticals Ltd (CU6)

Kategori

Historikk for aksjesplitt for Clarity Pharmaceuticals Ltd (CU6)
Aksjen Clarity Pharmaceuticals Ltd (symbol: CU6) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 30, 2026.
Én CU6-aksje kjøpt før Aug 30, 2026 tilsvarer i dag 0 CU6-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter